Piper Sandler Reiterates Overweight on Alkermes, Lowers Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Amsellem has reiterated an Overweight rating on Alkermes (NASDAQ:ALKS) but has lowered the price target from $38 to $37.
October 25, 2024 | 2:55 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Piper Sandler has reiterated an Overweight rating on Alkermes but reduced the price target from $38 to $37, indicating a slight decrease in expected valuation.
The reiteration of an Overweight rating suggests continued confidence in Alkermes' performance, but the slight reduction in the price target indicates a minor adjustment in expected valuation. This could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100